This HTML5 document contains 115 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q30845230
rdf:type
wikibase:Item
schema:description
سائنسی مضمون wissenschaftlicher Artikel vitskapeleg artikkel artigo científico (publicado na 2014) artigo científico artykuł naukowy artigo científico (publicado na 2014) scienca artikolo articolo scientifico bilimsel makale научная статья мақолаи илмӣ 2014年论文 artículo científico publicado en 2014 2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած bài báo khoa học article científic artikull shkencor vetenskaplig artikel videnskabelig artikel (udgivet 2014) 2014年論文 ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2014年论文 article scientific naučni članak vědecký článek tudományos cikk mokslinis straipsnis научни чланак 2014年论文 teaduslik artikkel επιστημονικό άρθρο مقالة علمية (نشرت في 2-8-2014) 2014年论文 2014 թվականի օգոստոսին հրատարակված գիտական հոդված artículu científicu espublizáu en 2014 מאמר מדעי 2014年論文 artikulong pang-agham мақолаи илмӣ სამეცნიერო სტატია tieteellinen artikkeli wetenschappelijk artikel vitenskapelig artikkel articol științific 2014年の論文 article scientifique (publié 2014) مقالهٔ علمی 2014年论文 บทความทางวิทยาศาสตร์ научна статия 2014년 논문 2014 nî lūn-bûn 2014年论文 научни чланак 2014年論文 2014年論文 vedecký článok наукова стаття, опублікована в серпні 2014 2014年論文 scientific article
p:P577
wds:Q30845230-3E777233-5CB3-492B-8455-45E6B248303C
wdt:P577
2014-08-02T00:00:00Z
p:P407
wds:Q30845230-4FBF7A50-D020-41D6-B7C0-CEC8DC1EE451
wdt:P407
wd:Q1860
p:P2093
wds:Q30845230-59CD6AC0-8800-4DAC-99D4-768952922F80
wdt:P2093
Isabella Testa
rdfs:label
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data
skos:prefLabel
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data
schema:name
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data
p:P50
wds:Q30845230-B854F2D0-E326-4346-BF81-99B8D028F40A wds:Q30845230-D4661401-6EE7-40E2-B90B-72ADBB5115D9 wds:Q30845230-E4571A57-5471-499F-9670-DA6847410CAA wds:Q30845230-902135C3-7765-4076-8D6B-76415F921617 wds:Q30845230-99B10190-8B4C-4A3D-AA50-9926CF43A9AB wds:Q30845230-A1EC1867-6BEF-43B5-9D93-8D35AE143449 wds:Q30845230-AFC72E8A-24EB-4B9D-A7E3-7919E93D19FB
wdt:P50
wd:Q37837953 wd:Q39606195 wd:Q39606238 wd:Q42343466 wd:Q56605918 wd:Q38359621 wd:Q57047350
p:P1476
wds:Q30845230-52F551D7-6C6C-4676-863A-414BECE1A0A2
wdt:P1476
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data
p:P304
wds:Q30845230-6BBD9CA4-7C23-4638-966C-DB5F8A1C0508
wdt:P304
137-141
p:P31
wds:Q30845230-E742EBB1-7E1E-403E-BC84-6A8BB24879B3 wds:Q30845230-A058F7C5-B302-4018-A56F-31F0146C0302 wds:Q30845230-F3873EA6-1213-4133-B194-8E6251DC7532
wdt:P31
wd:Q13442814 wd:Q1504425 wd:Q815382
p:P698
wds:Q30845230-CB2037BF-2118-41C2-93F4-29C52A5C13E1
wdtn:P698
n11:25160521
wdt:P698
25160521
p:P1433
wds:Q30845230-6A3DBF34-346E-4E0F-AE01-2C1D549A112C
wdt:P1433
wd:Q332266
p:P433
wds:Q30845230-B90DE42E-F3DA-4E85-A5F9-B1270412BBF9
p:P478
wds:Q30845230-C287E04D-6AC4-49C8-8862-028345BCC60C
wdt:P433
2
wdt:P478
13
p:P356
wds:Q30845230-04D604F1-3874-481C-B577-848DED86DC8C
wdtn:P356
n12:J.CLGC.2014.07.006
wdt:P356
10.1016/J.CLGC.2014.07.006
p:P5875
wds:Q30845230-F03B5033-406F-4DFA-99E6-10DEFC310D01
wdt:P5875
264426420